Serological evidence for the co-circulation of multiple dengue virus serotypes in Singapore

Epidemiology and Infection

Volumn 133, Issue 4, 2005, Pages 667-671

  Wilder Smith, Annelies ^a   Yoksan, Sutee ^b   Earnest, Arul ^a   Subramaniam, Ravathi ^a   Paton, Nicholas I ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DENGUE; DENGUE VIRUS; FEMALE; HUMAN; INCIDENCE; MALE; NORMAL HUMAN; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEROTYPE; SINGAPORE; VIRUS STRAIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COHORT STUDIES; CONFIDENCE INTERVALS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DNA, VIRAL; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; ODDS RATIO; PREVALENCE; PROBABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEROEPIDEMIOLOGIC STUDIES; SEROTYPING; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SINGAPORE;

EID: 22544479767     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268805003821     Document Type: Article

References (30)

1. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10: 100-103.
2. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2: 33-42.
3. Halstead SB. Is there an inapparent dengue explosion? Lancet 1999; 353: 1100-1101.
4. Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 1989; 11 (Suppl 4): S830-S839.
5. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181: 2-9.
6. Gibbons RV, Vaugh DW. Dengue: an escalating problem. Br Med J 2002; 324: 1563-1566.
7. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1: 55-57.
8. Ooi EE, Hart TJ, Tan HC, Chan SH. Dengue seroepidemiology in Singapore. Lancet 2001; 357: 685-686.
9. Goh KT. Dengue-a re-emerging infectious disease in Singapore. Ann Acad Med Singapore 1997; 26: 664-670.
10. Anonymous. Dengue surveillance in Singapore, 2002. Epidemiol News Bull 2003; 29: 7-9.
11. Wilder-Smith A, Foo W, Earnest A, Sremulanathan S, Paton NI. Seroepidemiology of dengue in the adult population of Singapore. Trop Med Int Health 2004; 9: 305-308.
12. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 1967; 99: 285-290.
13. Kow CY, Koon LL, Yin PF. Detection of dengue viruses in field caught male Aedes aegypti and Aedes albopictus (Diptera: Culicidae) in Singapore by type-specific PCR. J Med Entomol 2001; 38: 475-479.
14. Lorono-Pino MA, Cropp CB, Farfan JA, et al. Common occurrence of concurrent infections by multiple dengue virus serotypes. Am J Trop Med Hyg 1999; 61: 725-730.
15. Gubler DJ. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann Acad Med Singapore 1998; 27: 227-234.
16. Anonymous. Dengue fever/dengue haemorrhagic fever. In: Goh KT, ed. Communicable disease surveillance in Singapore. Singapore: Ministry of Environment Singapore, 2000.
17. Jatanasen S, Thongchaeron P. Dengue haemorrhaige fever in south-east Asian countries. In: Thongcharoen P, ed. Monograph on dengue/dengue haemorrhagic fever, vol. 22. WHO Regional Publication, SFARO. 1993: 23-30.
18. Halstead SB. Immune enhancement of viral infection. Prog Allergy 1982: 31: 301-364.
19. Halstead SB, Venkateshan CN, Gentry MK, Larsen LK. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol 1984; 132: 1529-1532.
20. Halstead SB, Streit TG, Lafontant JG, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 2001; 65: 180-183.
21. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1994; 75: 65-75.
22. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239: 476-481.
23. Anonymous. Committee for Disease Control. Prevalence of Japanese encephalitis virus infection in Singapore. Epidemiol News Bull 1994: 25-26.
24. Anonymous. Japanese encephalitis. Communicable disease surveillance in Singapore. Ministry of Environment, Singapore, 2000.
25. Paul FM. Japanese B. encephalitis in Singapore children. J Singapore Paediatr Soc 1978; 20: 13-17.
26. See E, Tan HC, Wang D, Ooi EE, Lee MA. Presence of hemagglutination inhibition and neutralization anti-bodies to Japanese encephalitis virus in wild pigs on an offshore island in Singapore. Acta Trop 2002; 81: 233-236.
27. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim-van Dillen PM, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 2002; 7: 331-338.
28. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998; 352: 971-977.
29. Schwartz E, Mileguir F, Grossman Z, Mendelson E. Evaluation of ELISA-based sero-diagnosis of dengue fever in travellers. J Clin Virol 2000; 19: 169-173.
30. Cuzzubbo AVD, Nisalak A, McBride J, Aaskov J, Devine P. Commercial assays for the serological diagnosis of dengue infections. In: Kay BH, Brown MD, Aaskov JG, eds. Arbovirus research in Australia. Papers from the Seventh Arbovirus Research in Australia Symposium and the Second Mosquito Control Association of Australia Conference, Surfers Paradise, vol. 7. Queensland: The Queensland Institute of Medical Research, 1997: 25-29.